Organon Business Development
Partnering with Organon. We believe in a better and healthier every day for every woman.
“We’re committed to leadership in women’s health, expanding our biosimilars portfolio, and building upon our global presence. At Organon, we believe in the power of collaboration. Working together, we can achieve far more for patients.”
Daniel Karp, Executive Vice President, Corporate Development
We aspire to be the partner of choice in our areas of focus
Women's health
We are committed to building a pipeline and portfolio of products to address her underserved needs. We seek opportunities in the areas of contraception, fertility, maternal and peripartum, and conditions that are unique to women or impact her differently.
Biosimilars
Our goal is to become the world class, global commercial partner of choice to biosimilar manufacturers and to expand our portfolio in oncology, immunology and beyond. We seek opportunities to collaborate with partners on programs that are expected to launch at or close to the loss of exclusivity of the reference product.
Established brands
Organon has a global footprint and broad portfolio of over 60 medicines and devices across a range of areas including dermatology, cardiovascular disease, neurology, autoimmune, and respiratory conditions. We seek collaborations that add products and are synergistic with our infrastructure and capabilities.
Key business development contacts
Daniel Karp
Executive Vice President, Corporate Development
Carol Ferguson
U.S. & Women’s Health Business Development
Troy Silfies
International & General Medicines Business Development
Abby Zhou
China Business Development
Satbir Kaur
Alliance Management & Integration
Jaquelina Lee
Corporate Development Operations
Parambir Bhangu
Search & Evaluation
Trudy Kohout
Search & Evaluation
To reach out for any other purpose, please visit the contact us page.